アジア太平洋のコロナウイルス検査キット市場2020-2024

◆英語タイトル:Coronavirus Test Kits Market in APAC 2020-2024
◆商品コード:IRTNTR43239
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年4月28日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:中国、インド、韓国、日本、その他アジア太平洋
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Coronavirus test kits market in APAC 2020-2024
Technavio has been monitoring the coronavirus test kits market in APAC and it is poised to grow by $ -50.15 million during 2020-2024 progressing at a CAGR of 32% during the forecast period. Our reports on coronavirus test kits market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current APAC market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of coronavirus and government initiative in creating awareness about coronavirus. In addition, increasing incidence of coronavirus is anticipated to boost the growth of the market as well.

The coronavirus test kits market in APAC market analysis includes end-user segment
Technavio’s coronavirus test kits market in APAC is segmented as below:
By End-user
• Government
• Non-government

This study identifies the new product launches as one of the prime reasons driving the coronavirus test kits market in APAC growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our coronavirus test kits market in APAC covers the following areas:
• Coronavirus test kits market in APAC sizing
• Coronavirus test kits market in APAC forecast
• Coronavirus test kits market in APAC industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in APAC vendors that include 3D Biomedicine Science & Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Maccura Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt Ltd., QIAGEN NV, and Thermo Fisher Scientific Inc.. Also, the coronavirus test kits market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/coronavirus-test-kits-market-in-apac-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End user
o Government – Market size and forecast 2019-2024
o Non-government – Market size and forecast 2019-2024
o Market opportunity by End user
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o China – Market size and forecast 2019-2024
o India – Market size and forecast 2019-2024
o South Korea (Republic of Korea) – Market size and forecast 2019-2024
o Japan – Market size and forecast 2019-2024
o Rest of APAC – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
• Drivers, Challenges, and Trends
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o 3D Biomedicine Science & Technology Co. Ltd.
o Abbott Laboratories
o BGI Genomics Co. Ltd.
o Co-Diagnostics Inc.
o F. Hoffmann-La Roche Ltd.
o Guangzhou Wondfo Biotech Co. Ltd.
o Maccura Biotechnology Co. Ltd.
o Mylab Discovery Solutions Pvt Ltd.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Parent market
• 8: Market characteristics
• 9: Offerings of vendors included in the market definition
• 10: Market segments
• 11: Global – Market size and forecast 2019 – 2024 ($ million)
• 12: Global market: Year-over-year growth 2019 – 2024 (%)
• 13: Five forces analysis 2019 & 2024
• 14: Bargaining power of buyers
• 15: Bargaining power of suppliers
• 16: Threat of new entrants
• 17: Threat of substitutes
• 18: Threat of rivalry
• 19: Market condition – Five forces 2019
• 20: End user – Market share 2019-2024 (%)
• 21: Comparison by End user
• 22: Government – Market size and forecast 2019-2024 ($ million)
• 23: Government – Year-over-year growth 2019-2024 (%)
• 24: Non-government – Market size and forecast 2019-2024 ($ million)
• 25: Non-government – Year-over-year growth 2019-2024 (%)
• 26: Market opportunity by End user
• 27: Customer landscape
• 28: Market share by geography 2019-2024 (%)
• 29: Geographic comparison
• 30: China – Market size and forecast 2019-2024 ($ million)
• 31: China – Year-over-year growth 2019-2024 (%)
• 32: India – Market size and forecast 2019-2024 ($ million)
• 33: India – Year-over-year growth 2019-2024 (%)
• 34: South Korea (Republic of Korea) – Market size and forecast 2019-2024 ($ million)
• 35: South Korea (Republic of Korea) – Year-over-year growth 2019-2024 (%)
• 36: Japan – Market size and forecast 2019-2024 ($ million)
• 37: Japan – Year-over-year growth 2019-2024 (%)
• 38: Rest of APAC – Market size and forecast 2019-2024 ($ million)
• 39: Rest of APAC – Year-over-year growth 2019-2024 (%)
• 40: Key leading countries
• 41: Market opportunity by geography ($ million)
• 42: Impact of drivers and challenges
• 43: Vendor landscape
• 44: Landscape disruption
• 45: Industry risks
• 46: Vendors covered
• 47: Market positioning of vendors
• 48: 3D Biomedicine Science & Technology Co. Ltd. – Overview
• 49: 3D Biomedicine Science & Technology Co. Ltd. – Product and service
• 50: 3D Biomedicine Science & Technology Co. Ltd. – Key offerings
• 51: 3D Biomedicine Science & Technology Co. Ltd. – Key customers
• 52: 3D Biomedicine Science & Technology Co. Ltd. – Segment focus
• 53: Abbott Laboratories – Overview
• 54: Abbott Laboratories – Business segments
• 55: Abbott Laboratories – Key offerings
• 56: Abbott Laboratories – Key customers
• 57: Abbott Laboratories – Segment focus
• 58: BGI Genomics Co. Ltd. – Overview
• 59: BGI Genomics Co. Ltd. – Product and service
• 60: BGI Genomics Co. Ltd. – Key offerings
• 61: BGI Genomics Co. Ltd. – Key customers
• 62: BGI Genomics Co. Ltd. – Segment focus
• 63: Co-Diagnostics Inc. – Overview
• 64: Co-Diagnostics Inc. – Product and service
• 65: Co-Diagnostics Inc. – Key offerings
• 66: Co-Diagnostics Inc. – Key customers
• 67: Co-Diagnostics Inc. – Segment focus
• 68: F. Hoffmann-La Roche Ltd. – Overview
• 69: F. Hoffmann-La Roche Ltd. – Business segments
• 70: F. Hoffmann-La Roche Ltd. – Key offerings
• 71: F. Hoffmann-La Roche Ltd. – Key customers
• 72: F. Hoffmann-La Roche Ltd. – Segment focus
• 73: Guangzhou Wondfo Biotech Co. Ltd. – Overview
• 74: Guangzhou Wondfo Biotech Co. Ltd. – Product and service
• 75: Guangzhou Wondfo Biotech Co. Ltd. – Key offerings
• 76: Guangzhou Wondfo Biotech Co. Ltd. – Key customers
• 77: Guangzhou Wondfo Biotech Co. Ltd. – Segment focus
• 78: Maccura Biotechnology Co. Ltd. – Overview
• 79: Maccura Biotechnology Co. Ltd. – Product and service
• 80: Maccura Biotechnology Co. Ltd. – Key offerings
• 81: Maccura Biotechnology Co. Ltd. – Key customers
• 82: Maccura Biotechnology Co. Ltd. – Segment focus
• 83: Mylab Discovery Solutions Pvt Ltd. – Overview
• 84: Mylab Discovery Solutions Pvt Ltd. – Product and service
• 85: Mylab Discovery Solutions Pvt Ltd. – Key offerings
• 86: Mylab Discovery Solutions Pvt Ltd. – Key customers
• 87: Mylab Discovery Solutions Pvt Ltd. – Segment focus
• 88: QIAGEN NV – Overview
• 89: QIAGEN NV – Product and service
• 90: QIAGEN NV – Key offerings
• 91: QIAGEN NV – Key customers
• 92: QIAGEN NV – Segment focus
• 93: Thermo Fisher Scientific Inc. – Overview
• 94: Thermo Fisher Scientific Inc. – Business segments
• 95: Thermo Fisher Scientific Inc. – Key offerings
• 96: Thermo Fisher Scientific Inc. – Key customers
• 97: Thermo Fisher Scientific Inc. – Segment focus
• 98: Currency conversion rates for US$
• 99: Research Methodology
• 100: Validation techniques employed for market sizing
• 101: Information sources
• 102: List of abbreviations



【掲載企業】

3D Biomedicine Science & Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Maccura Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt Ltd., QIAGEN NV, Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アジア太平洋のコロナウイルス検査キット市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆